Books › Medical Books › Research

Antipsychotic Long-acting Injections

Name: Antipsychotic Long-acting Injections
Price: 44.99 USD
Availability: InStock
Rating: 3 (1 reviews)

3.0 of 5 Stars: Research - Antipsychotic Long-acting Injections

$44.99

Buying Options

Description

Book Synopsis: Antipsychotic Long-acting Injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. Subsequently, first-generation antipsychotic LAIs became widely used in many countries. Since the initial publication of Antipsychotic Long-acting Injections in 2010, new trial data have been published on long-acting injection (LAI) preparations of the drugs Risperidone, Paliperidone, and Olanzapine. Furthermore, a new LAI preparation of the drug Aripiprazole has recently been approved for clinical use in the United States and is likely to be approved in Europe soon.
The second edition of this successful book has been fully updated to include this new data, with reference to both observational studies and randomized controlled trials, as well as other new developments in the clinical use of antipsychotic LAIs. New chapters have been added covering the comparison between oral and injectable antipsychotics, Olanzapine LAI, Aripiprazole LAI, and the practicalities of organizing a specialized clinic for long-acting injectable antipsychotics. Existing chapters have also been thoroughly updated to take into account the most recently published research.
Antipsychotic Long-acting Injections, Second edition brings together clinical and research findings on LAIs in a comprehensive volume, with chapters written by international experts.

Details

Are you looking for the latest research and updates on Antipsychotic Long-acting Injections (LAIs)? Look no further! Antipsychotic LAIs have proven to be a game-changer in improving treatment adherence for schizophrenia since the 1960s. Stay ahead of the curve with the second edition of our comprehensive book, which includes new trial data on Risperidone, Paliperidone, Olanzapine, and the newly approved Aripiprazole LAI. Trust the expertise of international experts and dive into the world of antipsychotic LAIs with our fully updated edition!

Stay informed and up-to-date with the latest developments in the clinical use of antipsychotic LAIs. Our second edition book covers a wide range of topics, including the comparison between oral and injectable antipsychotics, Olanzapine LAI, Aripiprazole LAI, and insights on organizing specialized clinics for long-acting injectable antipsychotics. With references to observational studies, randomized controlled trials, and recent research, you can trust that our book provides a comprehensive and authoritative guide to Antipsychotic Long-acting Injections.

Don't miss out on the opportunity to enhance your knowledge and understanding of Antipsychotic Long-acting Injections with our newly updated book. Whether you are a healthcare professional, researcher, or student in the field, this second edition is a must-have resource for staying informed and making evidence-based decisions. Explore the world of antipsychotic LAIs with confidence and equip yourself with the latest insights and findings!

Order Now

See All Buying Options...

More Details...